Ameritas Investment Partners’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.5K | Hold |
5,240
| – | – | ﹤0.01% | 2338 |
|
|
2025
Q1 | $39.7K | Hold |
5,240
| – | – | ﹤0.01% | 2242 |
|
|
2024
Q4 | $63.8K | Hold |
5,240
| – | – | ﹤0.01% | 2039 |
|
|
2024
Q3 | $87.7K | Buy |
5,240
+1,453
| +38% | +$24.3K | ﹤0.01% | 1876 |
|
|
2024
Q2 | $66K | Buy |
3,787
+1,188
| +46% | +$20.7K | ﹤0.01% | 1982 |
|
|
2024
Q1 | $44.3K | Buy |
2,599
+615
| +31% | +$10.5K | ﹤0.01% | 2221 |
|
|
2023
Q4 | $20.2K | Hold |
1,984
| – | – | ﹤0.01% | 2579 |
|
|
2023
Q3 | $18K | Hold |
1,984
| – | – | ﹤0.01% | 2594 |
|
|
2023
Q2 | $21.3K | Hold |
1,984
| – | – | ﹤0.01% | 2530 |
|
|
2023
Q1 | $20.3K | Hold |
1,984
| – | – | ﹤0.01% | 2461 |
|
|
2022
Q4 | $20.8K | Hold |
1,984
| – | – | ﹤0.01% | 2548 |
|
|
2022
Q3 | $25K | Hold |
1,984
| – | – | ﹤0.01% | 2403 |
|
|
2022
Q2 | $25K | Hold |
1,984
| – | – | ﹤0.01% | 2430 |
|
|
2022
Q1 | $21K | Hold |
1,984
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q4 | $31K | Hold |
1,984
| – | – | ﹤0.01% | 2417 |
|
|
2021
Q3 | $45K | Buy |
1,984
+916
| +86% | +$20.8K | ﹤0.01% | 2231 |
|
|
2021
Q2 | $28K | Hold |
1,068
| – | – | ﹤0.01% | 2542 |
|
|
2021
Q1 | $45K | Buy |
+1,068
| New | +$45K | ﹤0.01% | 2139 |
|